Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Recruiting · NCT04147286 · Registry updated 2024-08-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chronic Disease, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, chronic obstructive pulmonary disease, gram-positive bacterial infections, lung disorder, mycobacterial infectious disease, obstructive lung disease, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, tuberculosis | Recruiting | Phase 2 / Phase 3 | 2024-08-23 | NCT04147286 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Bern | 126 |
| University of Cape Town | 47 |
| University of Namibia | 1 |
| University of Stellenbosch | 31 |
| University of Zurich | 188 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| General Medicine & Global Health, Cape Heart Institute, Faculty of Health Sciences, University of Cape Town | Observatory | South Africa | 1 |